Search Results 2641-2650 of 13404 for monoclonal antibody

  1. Halting the circle: Comprehensive neurogenetics test panels - Mayo Clinic

    Mayo Clinic's test is a single evaluation that incorporates both antibodies commonly associated with NAM — HMGCR-IgG and SRP-IgG. The detection of SRP-IgG ...

  2. Diphtheria, tetanus, acellular pertussis, polio vaccine (intramuscular route) - Mayo Clinic

    The vaccine works by causing the body to produce its own protection (antibodies) against these diseases. This vaccine is given only to children 4 to 6 years ...

  3. Non-Hodgkin lymphoma - Doctors and departments - Mayo Clinic

    nstrom macroglobulinemia, Monoclonal gammopathy of undetermined significance ... Bispecific antibody therapy · Bone marrow biopsy · Bone marrow transplant ...

  4. Diphtheria and tetanus vaccine (intramuscular route) - Mayo Clinic

    The vaccine works by causing the body to produce its own protection (antibodies) against these diseases. This vaccine is given to children 6 weeks of age ...

  5. Study Of AG-120 In Previously Treated Advanced Cholangiocarcinoma With IDH1 Mutations (ClarIDHy) - Mayo Clinic

    Have known active hepatitis B (HBV) or hepatitis C (HCV) infections, known positive human immunodeficiency virus (HIV) antibody results, or acquired ...

  6. A Study Of Grapiprant And Pembrolizumab In Patients With Advanced Or Progressive MSS Colorectal Cancer - Mayo Clinic

    History of severe hypersensitivity reactions to chimeric or humanized antibodies. Has received prior systemic anticancer therapy including investigational ...

  7. Clinical trials - Oncology (Medical)

    ... antibodies and the factors that may determine disease progression and treatment response. Spinal Cord Stimulation to Treat Chemotherapy-Induced Peripheral ...

  8. Study Of Sacituzumab Govitecan-hziy And Pembrolizumab Versus Treatment Of Physician's Choice And Pembrolizumab In Patients With Previously Untreated, Locally Advanced Inoperable Or Metastatic Triple-Negative Breast Cancer (ASCENT-04) - Mayo Clinic

    participating in observational studies are eligible. - Have previously received topoisomerase 1 inhibitors or antibody drug conjugates containing a ...

  9. Dose Optimization And Expansion Study Of DFV890 In Adult Patients With Myeloid Diseases - Mayo Clinic

    For patients that received antibodies the washout period is 4 weeks prior to study treatment. History of hypersensitivity to the study treatment or its ...

  10. A Study to Evaluate the Safety and Effectiveness of CAEL-101 and Plasma Cell Dyscrasia Treatment vs. Placebo and Plasma Cell Dyscrasia Tretment to Treat Patients with Mayo Stage IIIb AL Amyloidosis

    Has POEMS (plasma cell dyscrasia with polyneuropathy, organomegaly, endocrinopathy, monoclonal protein and skin changes) syndrome or multiple myeloma ...